Higher Incidence of Protein-Losing Enteropathy in Patients with Single Systemic Right Ventricle

Alyssa M Bernardi1, Sylvestor Moses2, Brent J Barber3

  • 1Department of Pediatrics, University of Arizona, Tucson, USA.

Pediatric Cardiology
|September 25, 2020
PubMed

Insights

Patients with single ventricle congenital heart disease, particularly hypoplastic left heart syndrome (HLHS), face a higher risk of protein-losing enteropathy (PLE) after surgery compared to tricuspid atresia (TA). This suggests a single systemic right ventricle may be an independent risk factor for developing PLE.

Area of Science:

  • Pediatric Cardiology
  • Gastroenterology
  • Congenital Heart Disease

Background:

  • Patients with single ventricle congenital heart disease (SV-CHD) are susceptible to protein-losing enteropathy (PLE) post-surgical palliation.
  • Physiologic differences between single right and left ventricles may influence PLE incidence.

Purpose of the Study:

  • To investigate the hypothesis that right ventricular morphology is associated with a higher incidence of PLE.
  • To compare PLE incidence, outcomes, and costs between hypoplastic left heart syndrome (HLHS) and tricuspid atresia (TA).

Main Methods:

  • Retrospective review of over 15 million pediatric hospitalizations (ages 5-21) from 2000-2012.
  • Utilized Healthcare Cost and Utilization Project KID databases with ICD-9 codes for HLHS and TA.
  • Compared PLE incidence, patient age at admission, age of PLE onset, hospital outcomes, and costs.

Main Results:

  • PLE incidence was significantly higher in HLHS admissions (17.8%) compared to TA admissions (5.9%) (p < 0.001).
  • Admissions with PLE were older (12 vs 10 years, p < 0.001), and PLE onset occurred younger in HLHS (11 years) than TA (14 years).
  • No significant differences were found in hospital outcomes or costs between groups.

Conclusions:

  • Patients with HLHS demonstrate a higher incidence and younger age of onset for PLE compared to those with TA.
  • A single systemic right ventricle may represent an independent risk factor for developing PLE in pediatric patients with SV-CHD.
  • Further research is warranted to elucidate the mechanisms and optimize management of PLE in this population.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
222
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
208
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
302
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
333
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
485
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
267